(Q37507537)

20 August 2017

1 reference

title

The current classification of urothelial neoplasms (English)

1 reference

20 August 2017

David J Grignon

1

1 reference

20 August 2017

1 June 2009

1 reference

20 August 2017

1 reference

20 August 2017

22 Suppl 2

1 reference

20 August 2017

S60-9

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2008.235

20 August 2017

0 references

cites work

Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Review pathology in a diagnostic bladder cancer trial: effect of patient risk category

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Urothelial papillary (exophytic) neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

World Health Organization and International Society of Urological Pathology classification and two-number grading system of bladder tumors: reply.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

World Health Organization and International Society of Urological Pathology classification and two-number grading system of bladder tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Non-invasive urothelial neoplasms: according to the most recent WHO classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

The pathology of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Carcinoma in situ of the urinary bladder. Clues to host involvement in human carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

The role of immunohistochemistry in the diagnosis of urinary bladder neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Cytokeratin 20 and Ki-67 to distinguish carcinoma in situ from flat non-neoplastic urothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Urinary bladder. Mimics of neoplasia and new pathologic entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Is surveillance necessary for inverted papilloma in the urinary bladder and urethra?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Management of low grade papillary bladder tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Low risk bladder tumors--less is more!

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Eliminate the term "superficial" bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Flat intraepithelial lesions of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Natural history of urothelial dysplasia of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

NATURAL HISTORY AND CLINICAL BEHAVIOR OF IN SITU CARCINOMA OF THE HUMAN URINARY BLADDER

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Papillary urothelial hyperplasia. A precursor to papillary neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Urothelial papilloma of the bladder. Clinical and biologic implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Natural history of urothelial inverted papilloma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Atypia in inverted urothelial papillomas: pathology and prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Papillary urothelial neoplasms of low malignant potential. Clinical and biologic implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.235

7 January 2021

10.1038/MODPATHOL.2008.235

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19494854